Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The study concluded that PKP1 is essential for skin integrity and hair growth, and its dysfunction causes the symptoms of ectodermal dysplasia/skin fragility syndrome.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

The extracellular matrix is crucial for controlling skin stem cell behavior and health.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Endo-HSE helps grow hair-like structures from human skin cells in the lab.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.